Ibudol

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ibudol

Property Description
Active ingredient Ibuprofen
Form Tablet, capsule, suspension, suppository, or topical gel
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
General purpose Relief of pain, inflammation, and fever
Origin Synthetic propionic acid derivative

The Foundational Identity: Ibudol and its Pharmacological Class

Ibudol is a medicinal product containing the active ingredient Ibuprofen, a widely utilized compound clinically recognized for its efficacy and classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). Ibuprofen is chemically defined as a propionic acid derivative, confirming its status as a synthetic compound within a specific chemical family. Ibuprofen is approved for its analgesic, antipyretic, and anti-inflammatory activities, demonstrating its core function as a multifaceted agent for symptomatic relief. Ibudol is a single-ingredient product, and its pharmacological actions are exclusively derived from the well-established properties of the Ibuprofen molecule.


Physical Composition and Forms of Ibudol

The active substance Ibuprofen is formulated with pharmaceutical excipients to produce diverse dosage forms for targeted delivery. While oral forms, such as tablets and capsules, are the most widespread, Ibudol also presents in flexible versions like the oral suspension. Furthermore, the medicine is manufactured as suppositories for rectal administration or as topical gels for direct cutaneous application. This broad availability of dosage forms ensures the active ingredient can be delivered effectively for both localized and widespread systemic effects.


General Purpose: Managing Pain, Inflammation, and Fever

The utility of Ibudol is fundamentally based on its capacity to interrupt the biochemical pathways that generate symptomatic discomfort. This is achieved through the compound’s mechanism of modulating the synthesis of prostaglandins, which are key localized messengers that mediate pain perception and initiate the body's inflammatory and fever responses. Ibuprofen works by inhibiting cyclooxygenase (COX) enzymes, which are essential to this prostaglandin production. This action means Ibudol is typically used in situations like managing the acute discomfort associated with a common muscle strain or during periods of elevated body temperature, where it generally helps to diminish painful sensations, mitigate swelling, and reduce fever.

Regulatory References

  1. National Library of Medicine
  2. NIH StatPearls: Ibuprofen

What side effects are possible with Ibudol ?

Possible Side Effects and Safety Information

Ibudol (ibuprofen) is associated with a safety profile documented by government regulatory agencies, which classifies potential adverse reactions by frequency and body system. This information helps structure the understanding of the medicine’s risk.

Adverse Reaction Scope

Classification Examples of Reactions
Common (Affecting up to 1 in 10 people) Gastrointestinal disturbances (such as dyspepsia, nausea, vomiting, flatulence, diarrhea), headache, and dizziness.
Uncommon (Affecting up to 1 in 100 people) Hypersensitivity reactions (e.g., urticaria, pruritus), gastrointestinal ulceration or bleeding, visual disturbances, and various skin rashes.

Serious Safety Considerations

Regulatory documents emphasize the risk of serious adverse reactions affecting major organ systems. These include severe gastrointestinal events such as bleeding and perforation, and a small increased risk of arterial thrombotic events (heart attack or stroke), particularly when the medicine is used at high daily doses (2400 mg or higher) or for prolonged periods.

Severe allergic reactions and serious cutaneous reactions (e.g., Stevens-Johnson syndrome) are rare but documented risks that require immediate medical attention.

Safety Restrictions

Ibudol is contraindicated in certain high-risk situations, including the third trimester of pregnancy due to the potential for complications to the fetus. It is also restricted for use in patients with active or a history of recurrent peptic ulcers, severe heart failure, or severe hepatic or renal impairment. Caution is specifically noted for elderly patients, who may experience more frequent and severe adverse reactions, especially gastrointestinal bleeding.

Overdose and Emergency Response

Overdose and When to Seek Help

Ibudol (Ibuprofen) overdose requires immediate medical attention. In case of a suspected overdose, contact a Poison Control Center or get emergency medical help right away, even if no symptoms are immediately apparent.

Documented Overdose Manifestations

Symptoms of an acute overdose, as noted in official regulatory information, can include:

  • Gastrointestinal: Nausea, vomiting, epigastric pain, and diarrhea.
  • Central Nervous System (CNS): Drowsiness, lethargy, dizziness, severe headache, and ringing in the ears (tinnitus).
  • Severe Signs: Bradycardia, low blood pressure (hypotension), and respiratory depression.

Serious Outcomes and Emergency Action

Regulatory documents emphasize the risk of life-threatening complications. Seek urgent medical attention if any of the following severe outcomes occur or are suspected:

  • CNS: Decreased level of consciousness, seizures, or coma.
  • Organ Damage: Acute renal failure (kidney), severe metabolic acidosis, or gastrointestinal hemorrhage (bleeding).

There is no specific antidote for Ibudol overdose. Treatment in a medical setting focuses on supportive care and the management of symptoms. Decontamination measures, such as activated charcoal, may be used if ingestion occurred recently. Monitoring of vital signs, laboratory tests, and continuous observation for organ damage are key components of hospital management.

Therapeutic Uses of Ibudol

What Ibudol Treats: Main Uses and Benefits

Ibudol is commonly used in situations involving certain distressing symptoms, applied across domains where additional symptomatic support may be appropriate. This medication is relevant for easing symptom clusters that may become intense or disruptive.

It is relevant for managing conditions characterized by periods of heightened symptoms such as elevated body temperature (fever), general physical discomfort, and pain associated with inflammatory or irritative states. Common use scenarios include acute episodes of pain from headaches, muscle aches, toothaches, and discomfort from sprains or menstrual cramps.

“Ibudol is commonly used when short-term symptomatic assistance is appropriate for acute discomfort.”

The medication provides support that helps ease the overall symptom burden, particularly when symptoms interfere with routine activities. It may assist with maintaining functional stability during symptomatic periods and contributes to easing discomfort during symptomatic periods.


Quick Fact: Relief for Physical Discomfort and Fever


Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Ibudol, which contains the active ingredient ibuprofen, is a common non-steroidal anti-inflammatory drug (NSAID) generally safe for use by most adults and children over six months old, provided the dose is appropriate for age and weight. However, certain underlying health conditions and concurrent medications may make its use unsafe or require medical supervision.


Contraindications (Do Not Use)

Ibudol is not recommended for individuals with the following conditions:

  • Hypersensitivity: A previous allergic reaction (e.g., asthma, hives, or swelling) to aspirin, ibuprofen, or any other NSAID.
  • Active Gastrointestinal Issues: Current stomach ulcers, or active bleeding/perforation in the stomach or intestines.
  • Severe Organ Dysfunction: Severe heart failure, or severe liver or kidney disease.
  • Peripartum Period: During the last trimester of pregnancy (after 20 weeks), and immediately before or after heart bypass surgery (CABG).

Precautions (Use with Caution)

Consult a healthcare professional before using Ibudol if you have a history of:

  • Cardiovascular Conditions: Heart disease, high blood pressure, previous heart attack or stroke.
  • Gastrointestinal History: Previous stomach bleeding or ulcers.
  • Respiratory Issues: Asthma or aspirin-sensitive asthma.
  • Other Conditions: Bleeding disorders, Crohn’s disease, ulcerative colitis, or moderate liver/kidney impairment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Ibudol (Ibuprofen) interacts with various medicinal products and substances, primarily through pharmacodynamic effects and alteration of drug plasma concentrations. This information is derived from official regulatory labeling and should be reviewed by healthcare professionals.

Contraindicated Combinations

Ibudol is contraindicated with the concurrent use of other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), including cyclooxygenase-2 (COX-2) inhibitors, due to the significantly increased risk of adverse events, particularly gastrointestinal bleeding. High-dose Aspirin used for pain or inflammation is also contraindicated.

Clinically Significant Interactions

Interacting Product Category Regulatory Basis for Interaction
Anticoagulants/Antiplatelets Increased risk of serious bleeding due to additive antiplatelet/mucosal effects.
Corticosteroids & SSRIs Increased risk of gastrointestinal ulceration or bleeding.
Antihypertensives & Diuretics Potential for Ibudol to reduce the efficacy of these agents and increase the risk of renal impairment.
Lithium & Methotrexate Ibudol may decrease the renal clearance of these drugs, leading to elevated plasma concentrations and potential toxicity.
CYP2C9 Inhibitors Co-administration may increase Ibudol plasma levels (AUC/Cmax) due to inhibited metabolism.

Administration Requirements

Specific timing is required when Ibudol is co-administered with low-dose Aspirin used for cardioprotection. Regulatory labels advise a minimum separation of dose timing to prevent Ibudol from compromising the antiplatelet effect of the Aspirin.

Alcohol consumption increases the risk of gastrointestinal toxicity and bleeding when combined with Ibudol.

Mechanism of Action

The pharmacological action of Ibudol is driven by the active ingredient Ibuprofen, which operates by targeting a critical step in the body's eicosanoid synthesis pathway. This action results in three distinct physiological modulations across different systems.

Targeting the Cyclooxygenase Enzyme System

Ibudol's core mechanism is its function as a non-selective, reversible competitive inhibitor of the Cyclooxygenase (COX) enzymes ( COX-1 and COX-2). By blocking the active site of these enzymes, the drug prevents the conversion of arachidonic acid into prostaglandins ( PGE2, PGI2, etc.). This action directly modulates key pathways involving eicosanoid mediator synthesis by suppressing the formation of essential signaling molecules.

Decentralized Modulation of Nociceptor Signaling

The resulting reduction of prostaglandins at peripheral sites of tissue irritation reduces the PGE2-mediated sensitization of nociceptor nerve endings. The mechanism facilitates the reduction of PGE2 signaling, leading to decreased nociceptor excitability.

Normalization of Hypothalamic Thermoregulation

The drug's enzyme inhibition extends to the hypothalamus in the brain, where it blocks the PGE2-mediated elevation of the body's thermoregulatory set point. This action engages mechanisms that regulate thermal processes, allowing the set point to return to baseline, which initiates heat dissipation mechanisms.

Dosage and Administration Information

Official Administration Guidelines for Ibudol

Ibudol (Ibuprofen) administration is governed by the principle of utilizing the lowest effective dosage for the shortest duration of treatment. The medicine is available for both oral administration (tablets, capsules, and suspension) and intravenous (IV) infusion for use in specialized hospital settings.


Dosage and Frequency

Usage Category Standard Dose / Frequency Maximum Daily Dose
Oral (OTC/Acute) 200 mg to 400 mg every 4–6 hours 1200 mg
Oral (Prescription) 1200 mg to 3200 mg per day in divided doses 3200 mg
IV (Adult) 400 mg to 800 mg every 6 hours 3200 mg

Administration Context

For oral forms, administration with food or milk is permitted if the medicine causes gastrointestinal discomfort. Liquid suspensions must be shaken before use, and doses must be measured using the dedicated calibrated device provided with the product. Intravenous formulations require dilution prior to infusion and must be administered slowly over a period of at least 30 minutes.

Population-Specific Rules

Dosage for children (pediatrics) is calculated by body weight (mg/kg) rather than a fixed standard dose, with established limits on the total daily amount. Older adults and patients with mild to moderate hepatic or renal impairment are instructed to use the lowest possible dose for the briefest duration necessary, due to the increased sensitivity of these populations. For acute use, oral administration should generally be limited to 10 days.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Ibudol


Research Evidence for Acute Pain Management

This section will summarize the structure of clinical research, including randomized controlled trials and meta-analyses, that investigated Ibudol in research exploring short-term pain such as headaches, dental pain, sprains, and muscle aches. The focus will be on the types of outcomes measured in these acute settings.

Studies explored Ibudol in research contexts involving physical discomfort stemming from conditions associated with acute or disruptive episodes. Studies were typically conducted as short-term Randomized Controlled Trials (RCTs), where researchers measured changes in pain intensity using standardized patient-reported outcomes over short observation periods, often lasting only a few hours up to 24 hours post-dose. These studies describe patterns observed in the measured pain scores and the time interval monitored for patients to report changes in their physical discomfort.


Research Evidence for Fever and Symptom Reduction

Research examining Ibudol in contexts related to physiological strain or stress, particularly fever, primarily involves Randomized Controlled Trials and comparative studies. Research was studied for episodes where symptoms become more noticeable, such as elevated body temperature, in both adult and pediatric populations. The studies monitored specific measurements of the change in body temperature and the time interval to the observed change. Research provides insight into short-term changes, but the studies were conducted almost exclusively during acute, short-course treatment periods (e.g., 24 hours), which means long-term effects are not fully established for sustained fever management.


Research Evidence for Chronic Inflammatory States

Studies monitored Ibudol in research contexts examining outcomes related to functional imbalance and conditions characterized by functional limitations, such as chronic inflammatory states. The research includes both Randomized Controlled Trials and observational studies focused on adult and older adult populations. Studies explored changes measured during the study period, such as joint pain reduction and measured change on physical function scales (e.g., WOMAC Index). Findings indicate that research highlights changes measured during short-to-intermediate treatment periods (e.g., 2 to 6 weeks). However, the long-term effects for these chronic conditions are not fully established, and evidence quality varies across studies, particularly when looking at specific nuances.


What is Still Uncertain About Ibudol Research

Evidence highlights what is known—and what is still uncertain—about Ibudol. A key limitation is that long-term effects are not fully established, particularly for continuous use in chronic conditions. Follow-up durations were limited in most acute pain studies, and data for certain groups remain insufficient, especially for older adults or individuals with specific underlying health conditions. Furthermore, research into symptomatic outcomes is widely available, but the evidence quality varies across studies when looking at specific nuances, and subgroup findings are uncertain in many areas.

Key Studies & References

  1. Ibuprofen: MedlinePlus Drug Information (used for general indications, special populations, and chronic use context)
  2. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) - StatPearls (used for general classes, chronic conditions, and safety context)

Frequently Asked Questions (FAQ)

Common questions about Ibudol (FAQ)


Q: Does Ibudol primarily relieve pain or treat inflammation?

Ibudol is approved for multiple uses, including pain relief, inflammation reduction, and fever reduction. Its mechanism of action targets the chemical messengers called prostaglandins, which are involved in all three processes. Official product information describes its function as a multifaceted agent for symptomatic relief.


Q: Is Ibudol considered a fast-acting pain relief medicine?

Official information indicates that for most people, the pain-relieving effects of the oral forms begin to work relatively quickly. The onset of action is often reported to start within 20 to 30 minutes after the medicine is taken.


Q: How long does the pain-relieving effect of Ibudol generally last?

Studies and official information indicate that the duration of pain relief is generally consistent with the therapeutic interval established in the recommended dosing frequency. This means the effect is consistent with the need for re-dosing to maintain ongoing relief.


Q: Is Ibudol generally safe for individuals who have high blood pressure?

Regulatory documents note that individuals with a history of high blood pressure (hypertension) is noted to require appropriate monitoring when using Ibudol. This is because nonsteroidal anti-inflammatory drug (NSAID) therapy has been associated with reports of fluid retention and, in some cases, elevated blood pressure.


Q: What are the common signs of an allergic reaction to Ibudol?

According to official adverse reaction data, common signs of a potential allergic reaction include skin rashes, itching, and the appearance of hives (urticaria). The official label also notes that Ibudol carries a risk of worsening pre-existing conditions like asthma.


Q: What does the term 'nonsteroidal anti-inflammatory drug' mean in simple terms?

Ibudol is classified as a nonsteroidal anti-inflammatory drug, or NSAID. The term 'nonsteroidal' is used simply to indicate that this type of anti-inflammatory medicine is chemically distinct from other anti-inflammatory drugs that contain steroids (corticosteroids).


Q: Why is Ibudol often recommended for period pain and muscle aches?

Ibudol works by modulating the body's production of prostaglandins, which are key chemical messengers. These prostaglandins are responsible for signaling both pain and inflammation, including the discomfort associated with muscle strains and menstrual periods.


Q: How is Ibudol different from acetaminophen (paracetamol)?

Official pharmacological classifications show a key difference between Ibudol and acetaminophen. Ibudol is an NSAID, meaning it provides both pain relief and reduces inflammation. Acetaminophen, in contrast, is primarily used for pain relief and fever but does not have significant anti-inflammatory activity.


Q: Should I be cautious about mixing Ibudol with cold and flu remedies?

Regulatory warnings advise caution because many non-prescription cold and flu remedies contain other active ingredients, including other NSAIDs or interacting substances. Regulatory documents state that combining Ibudol with another NSAID is generally contraindicated due to the significantly increased risk of adverse events.


Q: Can Ibudol be used by women who are breastfeeding?

Studies and official information indicate that Ibudol is generally considered compatible with breastfeeding. This is because extremely low levels of the active ingredient have been measured in breast milk, which is the basis for it often being considered compatible during lactation.


Q: Is Ibudol the same type of drug as naproxen?

Both Ibudol and naproxen are classified as Nonsteroidal Anti-inflammatory Drugs (NSAIDs) because they share a similar mechanism of action. However, official product information indicates that they have different recommended dosing frequencies and durations of effect in the body.


Q: What should I look for on a label to know if another product contains Ibudol?

The official labeling standards require that the active ingredient be clearly stated on all products. Patients can look for the name Ibuprofen in the label’s 'Active Ingredient' section.


Q: Is it possible to experience fluid retention or swelling when taking Ibudol?

Yes, regulatory warnings note that fluid retention, medically known as oedema, has been reported in association with NSAID therapy. This is a specific concern that is monitored for, particularly in patients who have a history of heart failure or high blood pressure.


Q: Is it safe to crush, cut, or chew Ibudol tablets or capsules?

Official administration instructions state that certain solid oral forms of the medicine, such as the tablets, should be swallowed whole. Regulatory documents contain warnings against breaking, crushing, or chewing the tablets, as this may cause irritation in the mouth and throat.


Q: What should I do if I notice a change in the color of my stool while taking Ibudol?

Regulatory patient information describes the symptom of black or tarry stools as a potential sign of serious gastrointestinal bleeding. This is a severe adverse reaction that is explicitly listed as a medical event that warrants prompt attention.


Q: Does Ibudol have a warning against use for pain associated with chickenpox?

Official warnings advise against the use of Ibudol for pain associated with chickenpox unless a healthcare professional has specifically advised it. This is because there is a reported association with a risk of serious skin reactions in this context.


Q: Is there any known connection between Ibudol use and changes in fertility?

Regulatory information notes that Ibudol may temporarily affect female fertility. This is linked to the drug's effect on ovulation. However, official documents describe this effect as generally reversible upon discontinuing the medicine.

How should Ibudol be stored and disposed of?

Official Storage and Disposal Instructions

Regulatory documents specify strict conditions for storing and disposing of Ibudol (ibuprofen) to maintain its stability and ensure safety.

Storage Requirements

Condition Requirement
Temperature Store at room temperature, typically below 25 C or 30 C.
Protection Keep in the original container/outer carton to protect from light and moisture.
Handling Do not freeze and ensure the container is tightly closed.
Child Safety Keep out of the reach of children, securing child-resistant caps properly.

Disposal

Disposal must adhere to regulatory guidelines to prevent environmental contamination. Unused or expired Ibudol should not be flushed down the toilet or poured into a drain unless specifically instructed. The preferred method is to return the medicine to a pharmacy or use an official drug take-back program. If a take-back program is unavailable, mix the medicine with an undesirable substance (like dirt or coffee grounds) and place the mixture in a sealed bag before disposal with household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ibudol  found in:

A-Z Index: